share_log

Janux Therapeutics Analyst Ratings

Janux Therapeutics Analyst Ratings

Janux 治療師評級
Benzinga ·  2023/11/08 21:54
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/08/2023 257.68% Wedbush → $24 Reiterates Outperform → Outperform
08/10/2023 257.68% Wedbush → $24 Reiterates Outperform → Outperform
08/09/2023 421.61% HC Wainwright & Co. → $35 Reiterates Buy → Buy
07/18/2023 257.68% Wedbush → $24 Reiterates Outperform → Outperform
07/18/2023 421.61% HC Wainwright & Co. → $35 Reiterates Buy → Buy
05/10/2023 257.68% Wedbush → $24 Reiterates → Outperform
05/10/2023 421.61% HC Wainwright & Co. → $35 Reiterates → Buy
04/06/2023 257.68% Wedbush → $24 Initiates Coverage On → Outperform
03/13/2023 421.61% HC Wainwright & Co. → $35 Reiterates → Buy
11/14/2022 — William Blair Initiates Coverage On → Outperform
07/06/2021 421.61% B of A Securities → $35 Initiates Coverage On → Buy
07/06/2021 — Cowen & Co. Initiates Coverage On → Outperform
07/06/2021 421.61% HC Wainwright & Co. → $35 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
11/08/2023 257.68% Wedbush → 24 美元 重申 跑贏大盤 → 跑贏大盤
08/10/2023 257.68% Wedbush → 24 美元 重申 跑贏大盤 → 跑贏大盤
08/09/2023 421.61% HC Wainwright & Co. → 35 美元 重申 購買 → 購買
07/18/2023 257.68% Wedbush → 24 美元 重申 跑贏大盤 → 跑贏大盤
07/18/2023 421.61% HC Wainwright & Co. → 35 美元 重申 購買 → 購買
05/10/2023 257.68% Wedbush → 24 美元 重申 → 跑贏大盤
05/10/2023 421.61% HC Wainwright & Co. → 35 美元 重申 → 購買
04/06/2023 257.68% Wedbush → 24 美元 啓動覆蓋範圍開啓 → 跑贏大盤
03/13/2023 421.61% HC Wainwright & Co. → 35 美元 重申 → 購買
11/14/2022 — 威廉布萊爾 啓動覆蓋範圍開啓 → 跑贏大盤
2021 年 6 月 7 日 421.61% B of A 類證券 → 35 美元 啓動覆蓋範圍開啓 → 購買
2021 年 6 月 7 日 — Cowen & Co. 啓動覆蓋範圍開啓 → 跑贏大盤
2021 年 6 月 7 日 421.61% HC Wainwright & Co. → 35 美元 啓動覆蓋範圍開啓 → 購買

What is the target price for Janux Therapeutics (JANX)?

Janux Therapeutics（JANX）的目標價格是多少？

The latest price target for Janux Therapeutics (NASDAQ: JANX) was reported by Wedbush on November 8, 2023. The analyst firm set a price target for $24.00 expecting JANX to rise to within 12 months (a possible 257.68% upside). 10 analyst firms have reported ratings in the last year.

Wedbush於2023年11月8日公佈了Janux Therapeutics（納斯達克股票代碼：JANX）的最新目標股價。該分析公司將目標股價定爲24.00美元，預計JANX將在12個月內升至12個月內（可能上漲257.68％）。去年有10家分析公司公佈了評級。

What is the most recent analyst rating for Janux Therapeutics (JANX)?

分析師對Janux Therapeutics（JANX）的最新評級是多少？

The latest analyst rating for Janux Therapeutics (NASDAQ: JANX) was provided by Wedbush, and Janux Therapeutics reiterated their outperform rating.

Wedbush提供了Janux Therapeutics（納斯達克股票代碼：JANX）的最新分析師評級，Janux Therapeutics重申了其跑贏大盤的評級。

When is the next analyst rating going to be posted or updated for Janux Therapeutics (JANX)?

Janux Therapeutics（JANX）的下一次分析師評級何時公佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Janux Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Janux Therapeutics was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Janux Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Janux Therapeutics的最新評級是在2023年11月8日公佈的，因此您應該預計下一個評級將在2024年11月8日左右公佈。

Is the Analyst Rating Janux Therapeutics (JANX) correct?

分析師對Janux Therapeutics（JANX）的評級是否正確？

While ratings are subjective and will change, the latest Janux Therapeutics (JANX) rating was a reiterated with a price target of $0.00 to $24.00. The current price Janux Therapeutics (JANX) is trading at is $6.71, which is within the analyst's predicted range.

儘管評級是主觀的，並且會發生變化，但重申了最新的Janux Therapeutics（JANX）評級，目標股價爲0.00美元至24.00美元。Janux Therapeutics（JANX）目前的交易價格爲6.71美元，在分析師的預測區間內。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論